-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$68.33230.42% Upside
Corbus Pharmaceuticals Holdings, Inc. Frequently Asked Questions
-
What analysts cover Corbus Pharmaceuticals Holdings, Inc.?
Corbus Pharmaceuticals Holdings, Inc. has been rated by research analysts at B.Riley Financial, Mizuho Securities, Oppenheimer, H.C. Wainwright, RBC Capital, Jefferies in the past 90 days.